These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31031466)

  • 1. Development and clinical evaluation of a dried urine spot method for detection of morphine among opioid users.
    Jain R; Quraishi R; Verma A; Ambekar A
    Indian J Pharmacol; 2019; 51(1):40-44. PubMed ID: 31031466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Dried Urine Spot Method to Screen Cotinine among Tobacco Dependents: An Exploratory Study.
    Jain R; Quraishi R; Verma A
    Indian J Psychol Med; 2017; 39(4):469-474. PubMed ID: 28852242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried urine spots for detection of benzodiazepines.
    Jain R; Quraishi R; Ambekar A; Verma A; Gupta P
    Indian J Pharmacol; 2017; 49(6):465-469. PubMed ID: 29674802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct tandem mass spectrometry for the simultaneous assay of opioids, cocaine and metabolites in dried urine spots.
    Otero-Fernández M; Cocho JÁ; Tabernero MJ; Bermejo AM; Bermejo-Barrera P; Moreda-Piñeiro A
    Anal Chim Acta; 2013 Jun; 784():25-32. PubMed ID: 23746404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of codeine positivity in urine of pain management patients.
    Colby JM; Wu AH; Lynch KL
    J Anal Toxicol; 2015 Jun; 39(5):407-10. PubMed ID: 25840440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
    Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
    J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dried urine spots - A novel sampling technique for comprehensive LC-MS
    Michely JA; Meyer MR; Maurer HH
    Anal Chim Acta; 2017 Aug; 982():112-121. PubMed ID: 28734350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
    Bertholf RL; Johannsen LM; Reisfield GM
    J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does therapeutic use of tapentadol cause false-positive urine screens for methadone or opiates?
    Mullins ME; Hock K; Scott MG
    Clin Toxicol (Phila); 2015 Jun; 53(5):493-4. PubMed ID: 25951899
    [No Abstract]   [Full Text] [Related]  

  • 10. Opiate DAU screening using dried urine specimens.
    Meany DL; Clarke W
    Clin Chim Acta; 2009 Mar; 401(1-2):188-9. PubMed ID: 19068209
    [No Abstract]   [Full Text] [Related]  

  • 11. Automated analysis of dried urine spot (DUS) samples for toxicology screening.
    Pablo A; Breaud AR; Clarke W
    Clin Biochem; 2020 Jan; 75():70-77. PubMed ID: 31707014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes.
    Andersson M; Stephanson N; Ohman I; Terzuoli T; Lindh JD; Beck O
    Drug Test Anal; 2014 Apr; 6(4):317-24. PubMed ID: 23720205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution program.
    Schneider HJ; Rühl B; Meyer K; Keller R; Backmund M
    Eur Addict Res; 2008; 14(4):186-9. PubMed ID: 18583915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users.
    Palamar JJ; Le A; Guarino H; Mateu-Gelabert P
    Drug Alcohol Depend; 2019 Jul; 200():161-167. PubMed ID: 31146203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Microgenics CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays for the detection of heroin use in forensic urine samples.
    Holler JM; Bosy TZ; Klette KL; Wiegand R; Jemionek J; Jacobs A
    J Anal Toxicol; 2004 Sep; 28(6):489-93. PubMed ID: 15516301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine drug testing for pain management.
    Magnani B; Kwong T
    Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.